Cargando…
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405629/ https://www.ncbi.nlm.nih.gov/pubmed/34462521 http://dx.doi.org/10.1038/s41598-021-97248-w |
| _version_ | 1783746366685577216 |
|---|---|
| author | Huang, Yen-Hsiang Tseng, Jeng-Sen Hsu, Kuo-Hsuan Chen, Kun-Chieh Su, Kang-Yi Yu, Sung-Liang Chen, Jeremy J. W. Yang, Tsung-Ying Chang, Gee-Chen |
| author_facet | Huang, Yen-Hsiang Tseng, Jeng-Sen Hsu, Kuo-Hsuan Chen, Kun-Chieh Su, Kang-Yi Yu, Sung-Liang Chen, Jeremy J. W. Yang, Tsung-Ying Chang, Gee-Chen |
| author_sort | Huang, Yen-Hsiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8405629 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84056292021-09-01 Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M Huang, Yen-Hsiang Tseng, Jeng-Sen Hsu, Kuo-Hsuan Chen, Kun-Chieh Su, Kang-Yi Yu, Sung-Liang Chen, Jeremy J. W. Yang, Tsung-Ying Chang, Gee-Chen Sci Rep Publisher Correction Nature Publishing Group UK 2021-08-30 /pmc/articles/PMC8405629/ /pubmed/34462521 http://dx.doi.org/10.1038/s41598-021-97248-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Huang, Yen-Hsiang Tseng, Jeng-Sen Hsu, Kuo-Hsuan Chen, Kun-Chieh Su, Kang-Yi Yu, Sung-Liang Chen, Jeremy J. W. Yang, Tsung-Ying Chang, Gee-Chen Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title_full | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title_fullStr | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title_full_unstemmed | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title_short | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
| title_sort | publisher correction: the impact of different first-line egfr-tkis on the clinical outcome of sequential osimertinib treatment in advanced nsclc with secondary t790m |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405629/ https://www.ncbi.nlm.nih.gov/pubmed/34462521 http://dx.doi.org/10.1038/s41598-021-97248-w |
| work_keys_str_mv | AT huangyenhsiang publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT tsengjengsen publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT hsukuohsuan publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT chenkunchieh publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT sukangyi publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT yusungliang publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT chenjeremyjw publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT yangtsungying publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m AT changgeechen publishercorrectiontheimpactofdifferentfirstlineegfrtkisontheclinicaloutcomeofsequentialosimertinibtreatmentinadvancednsclcwithsecondaryt790m |